Entries by granitewordpress

Bank Of Ireland Kernel Capital Funds £1.5m Investment In Causeway Sensors

Kernel Capital through The Bank of Ireland Kernel Capital Growth Funds (NI) has led an £1.5m investment in Queens University Belfast (QUB) campus company, Causeway Sensors. The investment comprised of £1.3M from the Bank of Ireland Kernel Capital Growth Fund NI and £250k from existing investor QUBIS. To make a new biological drug, pharmaceutical companies […]

THE BANK OF IRELAND KERNEL CAPITAL FUNDS – €5M Investment in Altratech

Kernel Capital are pleased to confirm that Altratech Ltd has completed a €5M investment round led by The Bank of Ireland Kernel Capital Growth Fund and Infinity Capital each investing €1.5M, Enterprise Ireland invested €500k and  Claret Capital are providing €1.5M venture debt facility.  “We are delighted to see the Bank of Ireland Kernel Capital […]

The Bank of Ireland Kernel Capital funds Dundalk-based Nova Leah secures US Investment

Kernel Capital confirms, that through The Bank of Ireland Kernel Capital Growth Fund II it has completed a further significant investment in Dundalk-based Nova Leah. This investment is part of a substantial round that includes new investor Northwell Ventures, the investment arm of Northwell Health, New York State’s largest healthcare provider. Additional funding has also […]

THE BANK OF IRELAND KERNEL CAPITAL FUND PORTFOLIO COMPANIES SWIFTQUEUE & ONCOMARK ACQUIRED

Kernel Capital confirm that Dedalus Group, a leading international healthcare software solutions provider, has acquired Kildare-based Swiftqueue Technologies Limited, a Kernel Capital portfolio company which specialises in hospital appointment and queue management. In addition Kernel Capital confirm that in recent weeks its portfolio company Oncomark, which is developing a prognostic test for breast cancer, has […]

B-Secur Complete US$12m Fund Raise

Kernel Capital are pleased to confirm that portfolio company B-Secur Ltd, a Belfast-based health tech company, has completed a total raise of £8.8 million (USD $12 million) of investment in 2021, with the latest round led by US-based First Capital Ventures and The Bank of Ireland Kernel Capital Growth Fund NI increasing its investment level […]

,

Kernel Capital lead €1.5M investment in Kianda

The Bank of Ireland Kernel Capital Funds Lead €1.5M Investment in Kianda Technolgies Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund, supported by Enterprise Ireland has led a €1.5M investment in Kianda Technologies.  Co-founded in 2016 by Osvaldo and Derya Sousa Dublin-based Kianda has created a cloud-based automation platform that allows users, […]

,

Kernel Capital invests in B-Secur

B-Secur Investment as COVID-19 accelerates demand. Kernel Capital are pleased to confirm that it has increased its investment in B-Secur Ltd, a Belfast-based Health Tech Company to £1.45M. Existing co-investors Accelerated Digital Ventures and new investors Clarendon Fund Managers, have also participated in the latest investment round which completed in August 2020.   B-Secur has […]

4 Kernel Capital Portfolio Companies rank in Business Clouds NI Tech 50

The Bank of Ireland Kernel Capital Growth Fund (NI) portfolio companies B-Secur, Automated Intelligence, Causeway Sensors and Datactics have all ranked in Business Clouds inaugural ranking of Northern Ireland’s most innovative technology companies. The final Northern Ireland Tech 50 was decided by a combination of judging panel and a public vote which attracted more than […]

HTC €3M INVESTMENT IN VR EDUCATION HOLDINGS

The Bank of Ireland Kernel Capital Funds portfolio company, publicly quoted VR Education Holdings (AIM: VRE / Euronext Growth: 6VR) has announced their intent to complete a €3M investment from HTC, one of the world’s leading technology companies. In addition, HTC and the Waterford-based Company will enter into a strategic partnership for the distribution and […]

HIBERGENE DIAGNOSTICS CE APPROVAL FOR COVID-19 TEST

HiberGene Diagnostics, a portfolio Company of the Bank of Ireland Kernel Capital Funds has been awarded a CE mark for a new rapid COVID-19 test which is now available for sale internationally.This announcement follows the completion of a clinical trial at the Mater Private Hospital. The low cost test deliver results within 60 minutes with […]